COMMUNIQUÉS West-GlobeNewswire

Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical
14/10/2024
TORONTO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (" Psyence Group " or the " Company ") (CSE: PSYG) hereby announces that it has entered into a debt-for-equity swap agreement (the " Debt Swap Agreement ") [...]
Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)
14/10/2024
First Phase 3 PDT study in patients with sBCC in the United States. Rigorous dual endpoints requiring complete clinical and cytological clearance of malignant lesions. Data now being analyzed, interim results expected [...]
Cookie Diet announces the launch of new Four-Week Program
14/10/2024
America's most convenient diet revealed: These famous weight-loss cookies make it easy to shred kilos AND there’s a money-back guarantee. SYDNEY, Australia, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Dr Siegal’s famous Cookie [...]
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology
14/10/2024
PONTE VEDRA, Fla., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
You’re Invited! WonderTree’s Innovative, Team-Based Clinic to Celebrate Grand Opening
14/10/2024
On Friday, October 18, WonderTree will be showcasing its model for child and adolescent mental healthcare WonderTree founders Dr. Stephanie Lavoie (left) and Dr. Michelle Fardella (right) ORANGEVILLE, Ontario, Oct. 14, [...]
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
14/10/2024
Combined company to expand portfolio of clinical & commercial-stage assets in fertility, oncology, and autoimmune diseases SARASOTA, Fla. and MIAMI, Oct. 14, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience (“INVO”) (NASDAQ [...]
Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)
14/10/2024
MIAMI, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that its submission entitled “Lomecel-B inhibition of [...]
TytoCare and Frontier Health Partner to Provide Virtual-First Primary Care to Individuals and Employees across the United States
14/10/2024
New Partnership Will Provide TytoCare Devices to Thousands of Frontier Members across the U.S., Enabling In-Home Diagnostics and Extending Convenient Access to Relationship-Based Primary Care NEW YORK, Oct. 14, 2024 ( [...]
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression
14/10/2024
Data selected for oral presentation reinforce previous findings on safety and efficacy MALVERN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing [...]
Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs
14/10/2024
Veteran medical device executive to drive regulatory and clinical strategy as Nexalin advances drug-free Deep Intracranial Frequency Stimulation (DIFS) technology for mental health treatment HOUSTON, TX, Oct. 14, 2024 ( [...]
Aprea Therapeutics to Present at Maxim 2024 Healthcare Virtual Summit
14/10/2024
DOYLESTOWN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic [...]
Novo Nordisk A/S - share repurchase programme
14/10/2024
Bagsværd, Denmark, 14 October 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek
14/10/2024
Transition will Minimize Downtime, Deliver Faster, More Cost-Effective Results, and Improve Overall Safety and Productivity NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (" [...]
NewGenIvf Receives Nasdaq Notification Regarding Minimum Bid Price
14/10/2024
BANGKOK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), today announced that on October 8, 2024, the Company received a letter (the “Deficiency Letter”) from the [...]
Sharps Technology, Inc. Announces Stockholders’ Approval of Reverse Stock Split Ratio and Effective Date
14/10/2024
NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe [...]
Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024
14/10/2024
PRINCETON, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2024 financial results on Monday, [...]
HeartFlow to Present Latest Data on AI-Enabled Coronary Artery Disease Management at TCT 2024
14/10/2024
Long-term outcomes data from ADVANCE-DK Registry with HeartFlow FFR CT and Plaque Analysis and ongoing clinical studies highlighting CCTA and FFR CT diagnostic pathway to be discussed in six presentations New data build [...]
Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
14/10/2024
ADELAIDE, Australia and CAMBRIDGE, Mass., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric [...]
MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30
14/10/2024
MARIETTA, Ga., Oct. 14, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the third quarter ended [...]

Pages